Siegfried Holding AG (0QQO.L)

873.00 -3.82 (-0.44%) At close: 06:08PM BST

Siegfried Holding AG

Untere Bruehlstrasse 4
Zofingen 4800
Switzerland
41 62 746 1111
https://www.siegfried.ch

Sector(s): 
Industry: 
Full-time employees: 3,819

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Wolfgang Wienand Ph.D.	Chief Executive Officer	2.23M	N/A	1972
Dr. Reto Suter Ph.D.	Chief Financial Officer	N/A	N/A	1971
Dr. Jurgen Roos Ph.D.	Chief Scientific Officer	N/A	N/A	1968
Dr. Luca Dalla Torre	General Counsel & Secretary	N/A	N/A	N/A
Mr. Peter Stierli	Head of Corporate Communications	N/A	N/A	N/A
Ms. Irene Wosgien	Chief Human Resources Officer	N/A	N/A	1973
Ms. Marianne Spane	Chief Business Officer of Drug Substances & Drug Products	N/A	N/A	1962
Mr. Enno Schweinberger Ph.D.	Head Global Quality Management DS - Zofingen	N/A	N/A	N/A
Daniel Nieper	Chief Strategy Officer	N/A	N/A	N/A
Mr. Marcel Imwinkelried	Chief Operating Officer Drug Products	N/A	N/A	1967

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CHF.

Description

Siegfried Holding AG, together with its subsidiaries, provides contract development and manufacturing of active pharmaceutical ingredients (API) and finished dosage forms to the pharmaceutical industry worldwide. It offers pharmaceutical and analytical development, process and analytical transfer, commercial manufacturing and packaging, and scale-up and clinical trial material production services. The company develops and produces APIs and intermediates, as well as finished dosage forms, including solid oral dosage forms, sterile and aseptic filling injectables, ophthalmics, and inhalative products. In addition, it provides APIs and controlled substances focusing on anesthetics, pain and addiction treatment applications, and central nervous and respiratory diseases, as well as caffeine for human health and nutrition; exclusive synthesis services comprising process and chemical development, analytical development, pilot manufacturing and scale-up, and commercial manufacturing; and viral vector manufacturing solutions. Further, the company licenses oral solid and sterile products; assembles registration dossiers; and offers a common technical document for products. Siegfried Holding AG was founded in 1873 and is headquartered in Zofingen, Switzerland.

Corporate governance

Siegfried Holding AG’s ISS governance QualityScore as of 1 April 2024 is 4. The pillar scores are Audit: 2; Board: 6; Shareholder rights: 1; Compensation: 3.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.